Recently, Limin Group announced receiving formal approval for the independent registration of its primary fungicide product, mancozeb technical, in Brazil. This approval significantly boosts Limin Group’s international market presence and aligns with its strategy to strengthen its global footprint through independent product registrations.
As of April 2025, Limin Group has secured independent registrations for five technical pesticide products in Brazil: mancozeb, difenoconazole, azoxystrobin, prothioconazole, and mesotrione. Brazil represents the largest global market for mancozeb, predominantly driven by its widespread use in combating soybean rust, a disease with growing resistance to conventional fungicides. Mancozeb’s multi-site mode of action and positive impacts on crop health have reinforced its critical status among Brazilian growers.
Limin Group, headquartered in China, is a leading global manufacturer and exporter of agrochemical products, especially fungicides. With over three decades dedicated to mancozeb’s R&D and production, the company has established industry benchmarks by creating the internationally recognized FAO standard for mancozeb. Its advanced production technologies and consistent product quality position Limin Group among the top global producers, serving a significant share of the international agrochemical market.
The recent approval in Brazil exemplifies Limin Group’s strategic ambition to expand independently into overseas markets. The company aims to leverage its robust production and innovation capabilities, offer localized support to its customers, and meet global agricultural needs by continuously delivering high-quality fungicides.
